Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Neurosonics Medical
AddedFeb 18, 2024
UpdatedJun 18, 2026
Neurosonics Medical

Neurosonics Medical

Neurosonics Medical: Pioneering brain tumor ablation with specialized ultrasound devices since 2018.

HQ
Baltimore, MD, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Neurosonics Medical, founded in 2018 and headquartered in Baltimore, Maryland, specializes in developing advanced ultrasound devices for brain tumor ablation. The company's core mission is to revolutionize neurosurgery by providing non-invasive, precise, and effective treatment options for brain tumor patients. Their cutting-edge technology aims to improve patient outcomes and reduce recovery times, positioning them at the forefront of medical innovation in the neurosurgical field.

Notable affiliated individuals include leading neurosurgeons and medical device experts who contribute their expertise to the company's development efforts. Neurosonics Medical has garnered attention from prominent investors in the healthcare sector, aiding in its rapid growth and technological advancements. The company has achieved significant milestones in clinical trials, demonstrating the efficacy and safety of their devices. Overall, Neurosonics Medical is making a substantial impact on the treatment of brain tumors, offering hope and improved quality of life for patients worldwide.

Neurosonics Medical - Quick Facts

When was Neurosonics Medical founded?

Neurosonics Medical was founded in 2018.

Where is Neurosonics Medical's headquarters located?

Neurosonics Medical's headquarters is located in Baltimore, MD, US.

When was Neurosonics Medical's last funding round?

Neurosonics Medical's most recent funding round was for $225k (USD) in January 2020.

How much has Neurosonics Medical raised to-date?

As of Jan 23, 2020, Neurosonics Medical has raised a total of $225k (USD).

How many employees does Neurosonics Medical have?

Neurosonics Medical has 2 employees as of Feb 4, 2024.

Neurosonics Medical - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Ultrasound
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified